Stock listing
Modalis Therapeutics Corporation
Selected listing: 4883 · TSE · JPY · JP
Modalis Therapeutics Corporation (Tokyo:4883), Health Technology. Latest release Sep 10, 2026: Exegenesis Bio and Modalis Collaborate to Advance MDL-201…
- Ticker
- Tokyo:4883
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Tokyo
- Currency
- JPY
About Modalis Therapeutics Corporation
The company focuses on developing innovative therapeutic solutions. Investors can find relevant information and updates about Modalis Therapeutics on its public company page.
Latest news from Modalis Therapeutics Corporation
Exegenesis Bio and Modalis Collaborate to Advance MDL-201 for Duchenne Muscular Dystrophy
September 10, 2026
(Correction) Regarding Corrections to the "Consolidated Financial Results for the Six Months Ended June 30, 2026 [Japanese GAAP]"
August 13, 2026
Consolidated Financial Results for the Six Months Ended June 30, 2026 [Japanese GAAP]
August 10, 2026
Business Plans and Matters Related to Growth Potential
July 14, 2026
Modalis Announces Publication in Human Gene Therapy of Study Demonstrating Efficient LAMA1 Gene Activation for the Treatment of LAMA2-CMD
December 24, 2025
Research Modalis Therapeutics Corporation
Modalis Therapeutics Corporation company profile
View the public company page for Modalis Therapeutics Corporation on 6ix.
Modalis Therapeutics Corporation news
Read company news and market updates connected to Modalis Therapeutics Corporation.
Modalis Therapeutics Corporation investor events
Find investor webinars, events, and replay context for Modalis Therapeutics Corporation.